--- title: Biomarker Assays CROs path: /services/biomarker-assays companies_count: 54 --- # Biomarker Assays CROs 54 published CROs match Biomarker Assays. Locations in this set include United States, China, United Kingdom, France, Australia, and India. Capabilities that show up most often in this set: Biologics (Other), Small Molecule, Biologics (Monoclonal Antibodies), Cell Therapy, and Gene Therapy. ## Matching companies - [ACM Global Laboratories](/companies/acmgloballab) - Global clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries. - [Accelevir](/companies/accelevirdx) - CLIA-certified CRO specializing in ultra-sensitive molecular analytics, custom immunology assays, and integrated virology-immunology workflows for cell therapies, gene editing, and infectious disease programs. - [Aliri Bioanalysis](/companies/aliribio) - Bioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise. - [Amador Bioscience](/companies/amadorbioscience) - Amador Bioscience provides bioanalysis and biomarker services, including LCMS, immunoassays, flow cytometry, and immunogenicity testing, alongside clinical pharmacology modeling and regulatory affairs support. Its labs are GLP compliant, and its teams work across the US, China, and Europe. - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [Axcelead Drug Discovery Partners, Inc.](/companies/axcelead) - Axcelead provides integrated drug discovery research services to pharmaceutical companies, biotech ventures, and academic institutions. Founded in 2017 from Takeda's drug discovery research base, the company offers expertise across small molecules, nucleic acids, antibodies, and multiple therapeutic modalities. - [Beantown Biotech](/companies/beantownbiotech) - Boston-based CRO specializing in assay development and biochemical & cellular screening for early-stage drug discovery, from target validation through lead optimization. - [BioAgilytix](/companies/bioagilytix) - Bioanalytical CRO specializing in pharmacokinetics, immunogenicity, biomarkers, and CMC analytics with 30+ years of experience and 1,100+ employees conducting 5M+ tests annually. - [BioDuro-Sundia](/companies/bioduro-sundia) - BioDuro-Sundia is a contract research, development, and manufacturing organization (CRDMO) with 30 years of expertise providing integrated drug discovery, development, and manufacturing services from target identification through IND submission. - [Biotest Facility](/companies/bioxpedia) - Danish CRO offering in vivo models, proteomics, transcriptomics, biomarker discovery, and bioinformatics to support biotech and pharma research from concept to validated data. - [Causaly](/companies/causaly) - Causaly is an agentic AI platform that accelerates R&D decision-making by turning scientific evidence into decision-ready intelligence through governed reasoning, knowledge graphs, and custom scientific workflows. - [Celerion](/companies/celerion) - Global CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience. - [Cellentia, Inc.](/companies/cellentiabio) - Specialized contract research organization offering custom bioassays, organoid culturing, AAV and MSD assays, PBMC isolation, and patient-derived 3D tumor organoid lines for drug development and translational research. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Champions Oncology](/companies/championsoncology) - Leading oncology CRO specializing in preclinical and clinical specialty testing, with over 1,400 patient-derived xenograft models, comprehensive multi-omic datasets, and proprietary platforms including flow cytometry, NGS, proteomics, and histopathology services. - [ChemPartner](/companies/chempartner) - Global preclinical CRO with 20+ years of experience supporting drug discovery through IND submission across small molecules and biologics, with 2,000+ scientists and facilities worldwide. - [Chimera Biotec GmbH](/companies/chimera-biotec) - Chimera Biotec offers GLP/GCP ultra-sensitive bioanalysis built on its proprietary Imperacer Immuno-PCR platform. Capabilities cover custom immunoassay development, assay transfer, and ADA/immunogenicity and PK/PD assays down to sub-pg/ml levels. - [Confluence Discovery Technologies, Inc.](/companies/confluencediscovery) - Full-service drug discovery CRO specializing in cell and molecular biology, biochemistry, enzymology, biomarker development, immunology, and in vivo efficacy models from idea through IND. - [Crown Bioscience](/companies/crownbio) - Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development. - [Fog City Bio](/companies/fogcitybio) - Specialized CRO for custom immunoassay development using Simoa, HTRF, AlphaLISA, Luminex, MSD ECL, and other platforms. Direct scientist communication with rapid optimization workflows.